We supply SEPITRAP™ innovative dry powdered solubilisers which are specifically developed to simplify the manufacturing process and at the same time improve the bioavailability of the active ingredients in the tablet or capsule. This solubilising excipient manufactured by using a patented manufacturing process, opens new possibilities for formulation and improving the bioavailability of active ingredients with low solubility.
SEPITRAP™ is a micro-encapsulated solubiliser in powder form specially designed for simplifying the manufacturing of solid oral dosage forms such as tablets and capsules. It is both a solid solubilizer and a compression agent that helps to improve bioavailability of the active ingredients (API), which makes it perfect for solid dosage forms involving APIs with low solubility. SEPITRAP™ can even be used in direct compression procedures without impacting the hardness and disintegration of the formed tablets.
The SEPITRAP™ is manufactured by absorption of the solubiliser in liquid form on a porous mineral carrier. The technology which is patented – is shown in the figure.
The SEPITRAP™ range consists of two solubilisers with different surfactants:
All the components of SEPITRAP™ comply with USP-NF. SEPITRAP™ is manufactured in accordance with IPEC GMP standards and is certified EXCiPACT.
The benefits of using SEPITRAP™ solubilisers include:
Lene Aarøe Nissen
Head of Nordic Sales
+45 22 70 10 02